Results 201 to 210 of about 35,587 (239)
Some of the next articles are maybe not open access.
Prevention and management of chemotherapy-induced nausea and vomiting
International Journal of Palliative Nursing, 2015Nausea and vomiting are among the most frequently experienced toxic side-effects associated with chemotherapy. Although nausea and vomiting can result from surgery or radiotherapy, chemotherapy-induced nausea and vomiting (CINV) is potentially the most severe and most distressing.
Saeed, Moradian, Doris, Howell
openaire +2 more sources
Fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting
Expert Review of Anticancer Therapy, 2012For patients receiving cancer chemotherapy, the ongoing development of antiemetic treatment is of significant importance. Patients consider nausea and vomiting among the most distressing symptoms of chemotherapy, and as new antiemetics have been very successful in prevention of vomiting, agents effective against nausea have become one of the major ...
Ruhlmann, Christina H. B. +1 more
openaire +3 more sources
Rolapitant: A Review in Chemotherapy-Induced Nausea and Vomiting
Drugs, 2017Oral rolapitant (Varubi™; Varuby®), a long-acting neurokinin-1 (NK1) receptor antagonist (RA), is indicated in the USA and EU as part of an antiemetic regimen to prevent delayed chemotherapy-induced nausea and vomiting (CINV) in adults receiving highly or moderately emetogenic chemotherapy (HEC or MEC).
Young-A, Heo, Emma D, Deeks
openaire +2 more sources
Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting
New England Journal of Medicine, 2016One of the most important changes in cancer treatment in recent decades has been the development of treatment regimens that greatly reduce the incidence and intensity of nausea and vomiting. The most effective regimens and how they work are reviewed.
Rudolph M, Navari, Matti, Aapro
openaire +2 more sources
[Nausea and vomiting induced by chemotherapy].
La Revue du praticien, 2019Nausea and vomiting induced by chemotherapy. Nausea and vomiting induced by chemotherapy impact heavily anticancer treatment safety. It is necessary to define correctly, assess frequently and treat perfectly, following national or international guidelines. New treatment are currently developed in the field of emesis protection.
Florian, Scotté +6 more
openaire +1 more source
Chemotherapy-Induced Nausea and Vomiting
Clinical Journal of Oncology Nursing, 2005Cynthia N, Rittenberg +1 more
openaire +3 more sources
Chemotherapy-Induced Nausea and Vomiting
Journal of Pharmaceutical Care in Pain & Symptom Control, 1998Chemotherapy-induced nausea and vomiting (CINV) impacts patient with cancer who are currently receiving chemotherapy. Risk factors identifying patients most likely to suffer from CINV are summarized. The pathophysiology of CINV is reviewed to provide rationale for recommending combination antiemetic therapy to optimally control CINV.
openaire +1 more source
Corticosteroids in the Treatment of Chemotherapy-Induced Nausea and Vomiting
Journal of the National Comprehensive Cancer Network, 2012Chemotherapy-induced nausea and vomiting (CINV) is one of the most feared side effects of cancer treatment, despite the advances over the past decades. Corticosteroids have been shown to be effective in the management of CINV. These agents are usually used in combination with serotonin antagonists and neurokinin-1 antagonists for highly or moderately ...
openaire +2 more sources
Rolapitant for the treatment of chemotherapy-induced nausea and vomiting
Expert Review of Anticancer Therapy, 2015Chemotherapy-induced nausea and vomiting is a significant clinical issue which affects patient's quality of life and treatment decisions. Significant improvements in the control of chemotherapy-induced nausea and vomiting have occurred in the past 15 years with the introduction of new antiemetic agents 5-HT3, receptor antagonists, neurokinin-1 (NK-1 ...
openaire +2 more sources
Cannabinoids in the Treatment of Chemotherapy-Induced Nausea and Vomiting
Journal of the National Comprehensive Cancer Network, 2012Before the introduction of the serotonin receptor antagonists (5-HT3 receptor antagonists) in the early 1990s, limited effective options were available to prevent and treat chemotherapy-induced nausea and vomiting (CINV). In 1985, the FDA approved 2 cannabinoid derivatives, dronabinol and nabilone, for the treatment of CINV not effectively treated by ...
openaire +2 more sources